NIH clinical trial tests remdesivir plus anti-inflammatory drug baricitinib for COVID-19
A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) ...
May 8, 2020
0
31